Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2022 | YoY |
|---|---|---|
| Revenue | 314.48k | 458.75% |
| Gross profit | -29.82k | 108.60% |
| Net profit | -529.48k | 51.60% |
| EBITDA | -503.88k | 52.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €582.46k |
Number of shares | 503.06m |
52-week high/low | €0.00116 - €0.00116 |
| Dividends | No |
Beta | -0.83 |
P/E ratio | -1.09 |
PEG ratio | -0.02 |
P/B ratio | -1.35 |
P/S ratio | 1.95 |
Company profile
NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
| Name | NeutriSci International |
| CEO | Glen Rehman |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| IPO | 07/09/2016 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Tsxv | NU.V |
Pnk | NRXCF |
Frankfurt | 1N9.F |
München | 1N9.MU |